Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pharm Bioallied Sci ; 16(Suppl 3): S1962-S1964, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-39346213

RESUMO

Tobacco use is a significant risk factor for periodontal disease, a chronic inflammatory condition affecting the supporting structures of the teeth. Early detection and intervention are crucial for preventing the progression of periodontal disease and its associated complications. This review paper explores recent innovations in the screening and diagnosis of periodontal disease, with a focus on advancements in technology and methodologies for assessing periodontal health in tobacco users. By examining the latest research findings and technological developments, this paper aims to highlight the potential of novel approaches to improve the early detection and management of periodontal disease in this high-risk population. In addition, it discusses the challenges and opportunities associated with implementing these innovations in clinical practice and public health settings.

2.
J Pharm Bioallied Sci ; 16(Suppl 3): S1959-S1961, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-39346313

RESUMO

Chronic respiratory illnesses, such as chronic obstructive pulmonary disease and asthma, pose significant challenges to public health worldwide. Mounting evidence suggests a bidirectional relationship between respiratory health and oral health, with periodontal disease emerging as a potential risk factor for the development and exacerbation of respiratory conditions. This review paper explores the complex interplay between periodontal disease and chronic respiratory illness, highlighting the importance of oral health maintenance in promoting respiratory well-being. By examining recent advancements in the prevention and diagnosis of periodontal disease, particularly in the context of chronic respiratory conditions, this paper aims to elucidate novel solutions and strategies for improving oral health outcomes and respiratory outcomes simultaneously. Through a comprehensive analysis of the literature and emerging research trends, this review sheds light on the potential benefits and challenges of integrating oral health into the management of chronic respiratory illnesses and identifies opportunities for future research and clinical practice.

3.
J Clin Diagn Res ; 10(10): ZD13-ZD16, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27891482

RESUMO

Chronic Lymphocytic Leukaemia (CLL) is a monoclonal lymphoid malignancy characterized by progressive accumulation of small, mature but functionally incompetent neoplastic lymphocytes in the peripheral blood, bone marrow and lymphoid organs. Patients present a variable course and may not require early intervention unlike other malignancies. Patients with rapidly deteriorating blood counts, and organomegaly need treatment. Alkylating agent live Bendamustine combined with Rituximab, anti-CD 20 monoclonal antibody have shown promising results in such patients. Anaemia, neutropenia and thrombocytopenia have been reported as treatment emergent events with this combination therapy. Neutrophils are the major innate defense and their depletion can result in a wide range of opportunistic infections. This case report discusess the oral and dermal lesions which emerged with the Rituximab and Bendamustine combination therapy in a patient with CLL and their management.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA